Home Infusion Therapy Market Analysis | 2023-2028

“The Home Infusion Therapy Market was estimated at US$ 32.12 billion in 2022 and is expected to grow at a CAGR of 8.2% during 2023-2028 to reach US$ 51.83 billion by 2028.”

Wish to get a free sample? Register Here

Market Dynamics

Introduction

Home infusion therapy refers to the administration of intravenous medications, fluids, or nutrition to patients in the comfort of their own homes. It involves the use of specialized equipment and skilled healthcare professionals who deliver these treatments to individuals with chronic illnesses, infections, or other medical conditions that require ongoing intravenous therapy.

Home infusion therapy offers numerous advantages, including increased convenience, reduced healthcare costs, improved patient satisfaction, and minimized risks of hospital-acquired infections. It allows patients to receive necessary treatments while maintaining their daily routines and enjoying a higher quality of life. Overall, home infusion therapy promotes accessible and personalized healthcare delivery in a familiar and supportive environment.

Market Drivers

The home infusion therapy market is influenced by several factors. The surging incidences of chronic diseases have steered the demand for long-term intravenous treatments outside of conventional healthcare settings. The rising geriatric population and the preference for cost-effective healthcare solutions also contribute to market growth. Technological advancements, such as portable infusion pumps and remote monitoring systems, enhance the feasibility and safety of home-based treatments.

Additionally, efforts undertaken by the government to promote home healthcare and the shift towards value-based care models further support market expansion. These factors create a favorable environment for growth and innovation in the home infusion therapy sector.

Segments Analysis

By Product Type

“The infusion pump segment dominates the market during the forecast period.”

The market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The infusion pump segment is estimated to maintain its dominance over the forecast period, owing to properties such as the delivery of fluids at precise programmed rates.

By Application Type

“The anti-infective segment accounts for the largest market share during the forecast period.”

The market is segmented into anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, and others. The anti-infective segment accounted for the largest share of the market in 2019 and is expected to maintain its dominance during the forecast period. The growth of the segment can be attributed to growing demand from antibiotic and anti-fungal medicine administrations.

Regional Analysis

“North America is projected to be the largest market during the forecast period.”

The North American market is expected to grow with a lucrative CAGR over the forecast period owing to well-developed healthcare infrastructure, the presence of skilled medical professionals, high adoption of advanced technology, and high healthcare expenditure.

Want to know which region offers the best growth opportunities? Register Here

Key Players

The market is highly populated with the presence of several local, regional, and global players. Most of the major players compete in some of the governing factors including price, product offerings, regional presence, etc.  

The following are the key players in the home infusion therapy market (arranged alphabetically).

• B Braun Melsungen AG
• Baxter International, Inc.
• Becton
• Cosmed.
• Dickinson and Company
• Eli Lilly and Company
• Fresenius Kabi
• ICU Medical Inc.
• JMS Co., Ltd.
• Smiths Medical.
• Terumo Corporation

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Option

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players)
• SWOT analysis of key players (up to 3 players)

Market Segmentation

• Current market segmentation of any one of the product types by application type.  

Competitive Benchmarking

• Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and Needleless connectors, please send your inquiry to sales@stratviewresearch.com.